Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion type Assertion NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_head.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion description "[To evaluate the predictive value of the disintegrin and metalloproteinases, ADAM-9, ADAM-10, ADAM-11, and ADAM-12, and of the matrix metalloproteinases, MMP-2 and MMP-9, in patients with recurrent breast cancer treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_provenance.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion evidence source_evidence_literature NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_provenance.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion SIO_000772 16243802 NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_provenance.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion wasDerivedFrom befree-20150227 NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_provenance.
- NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_assertion wasGeneratedBy ECO_0000203 NP564626.RAGGinrsafNhTFzACosWuSDwj19PluB0tks_f3d73YUPE130_provenance.